| Delivery of short interfering RNA using endosomolytic cell‐penetrating peptides P Lundberg, S El‐Andaloussi, T Sütlü, H Johansson, Ü Langel The FASEB Journal 21 (11), 2664-2671, 2007 | 389 | 2007 |
| Natural killer cell‐based immunotherapy in cancer: current insights and future prospects T Sutlu, E Alici Journal of internal medicine 266 (2), 154-181, 2009 | 312 | 2009 |
| Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components E Alici, T Sutlu, B Björkstrand, M Gilljam, B Stellan, H Nahi, HC Quezada, ... Blood 111 (6), 3155-3162, 2008 | 242 | 2008 |
| Inhibition of intracellular anti-viral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy T Sutlu, S Nyström, M Gilljam, B Stellan, SE Applequist, E Alici Human Gene Therapy 23 (10), 1090-1100, 2012 | 174 | 2012 |
| Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor T Sutlu, B Stellan, M Gilljam, HC Quezada, H Nahi, G Gahrton, E Alici Cytotherapy 12 (8), 1044-1055, 2010 | 139 | 2010 |
| Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study L Barkholt, E Alici, R Conrad, T Sutlu, M Gilljam, B Stellan, B Christensson, ... Immunotherapy 1 (5), 753-764, 2009 | 132 | 2009 |
| Triticum durum Metallothionein ISOLATION OF THE GENE AND STRUCTURAL CHARACTERIZATION OF THE PROTEIN USING SOLUTION SCATTERING AND MOLECULAR MODELING K Bilecen, UH Ozturk, AD Duru, T Sutlu, MV Petoukhov, DI Svergun, ... Journal of Biological Chemistry 280 (14), 13701-13711, 2005 | 86 | 2005 |
| Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model B Bestas, PMD Moreno, KEM Blomberg, DK Mohammad, AF Saleh, ... The Journal of clinical investigation 124 (9), 4067-4081, 2014 | 74 | 2014 |
| Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model E Alici, KV Konstantinidis, T Sutlu, A Aints, G Gahrton, HG Ljunggren, ... Experimental hematology 35 (12), 1839-1846, 2007 | 74 | 2007 |
| Clinical impact of chromosomal aberrations in multiple myeloma H Nahi, T Sutlu, M Jansson, E Alici, G Gahrton Journal of internal medicine 269 (2), 137-147, 2011 | 61 | 2011 |
| Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D EC Sayitoglu, AM Georgoudaki, M Chrobok, D Ozkazanc, BJ Josey, M Arif, ... Frontiers in Immunology 11, 40, 2020 | 48 | 2020 |
| Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS D Yoyen-Ermis, G Tunali, E Tavukcuoglu, U Horzum, D Ozkazanc, T Sutlu, ... Scientific reports 9 (1), 11697, 2019 | 38 | 2019 |
| Engineering antigen‐specific NK cell lines against the melanoma‐associated antigen tyrosinase via TCR gene transfer A Parlar, EC Sayitoglu, D Ozkazanc, AM Georgoudaki, C Pamukcu, ... European journal of immunology 49 (8), 1278-1290, 2019 | 38 | 2019 |
| Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma H Nahi, M Chrobok, S Meinke, C Gran, N Marquardt, G Afram, T Sutlu, ... Cell Reports Medicine 3 (2), 2022 | 34 | 2022 |
| The prognostic significance of 8p21 deletion in multiple myeloma T Sutlu, E Alici, M Jansson, A Wallblom, MS Dilber, G Gahrton, H Nahi British journal of haematology 144 (2), 266-268, 2009 | 30 | 2009 |
| Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells M Chrobok, CIM Dahlberg, EC Sayitoglu, V Beljanski, H Nahi, M Gilljam, ... Cancers 11 (1), 69, 2019 | 23 | 2019 |
| Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet’s disease severity T Kahraman, G Gucluler, I Simsek, FC Yagci, M Yildirim, C Ozen, A Dinc, ... Journal of extracellular vesicles 6 (1), 1284449, 2017 | 22 | 2017 |
| Deletion of chromosomal region 8p21 confers resistance to bortezomib and is associated with upregulated decoy TRAIL receptor expression in patients with multiple myeloma AD Duru, T Sutlu, A Wallblom, K Uttervall, J Lund, B Stellan, G Gahrton, ... PloS one 10 (9), e0138248, 2015 | 19 | 2015 |
| Retroviral gene transfer into primary human natural killer cells E Alici, T Sutlu, M Sirac Dilber Methods Mol Biol 506, 127-37, 2009 | 18 | 2009 |
| Plasmonic selection of ssDNA aptamers against fibroblast growth factor receptor H Kurt, AE Eyüpoğlu, T Sütlü, H Budak, M Yüce ACS combinatorial science 21 (8), 578-587, 2019 | 14 | 2019 |
Adil Doganay DuruAssistant Profesor at Nova Southeastern UniversityVerified email at nova.edu
